Search. Read. Cite.

Easy to search. Easy to read. Easy to cite with credible sources.

Diabetic Medicine

Year: 2010  |  Volume: 27  |  Issue: 9  |  Page No.: 1060 - 1065

Psychosocial factors associated with use of continuous glucose monitoring

M. D. Ritholz, A. Atakov-Castillo, M. Beste, E. A. Beverly, A. Leighton, K. Weinger and H. Wolpert

Abstract

Aims  To identify psychosocial factors associated with the use of continuous glucose monitoring by adults with Type 1 diabetes.

Methods  Twenty adult patients (aged 45 ± 15 years, diabetes duration 25 ± 19 years, 50% female) followed at our site in the multi-centre Juvenile Diabetes Research Foundation continuous glucose monitoring trial were divided into three groups: Glycated haemoglobin (HbA1c) Responders who demonstrated an improvement in glycaemic control with continuous glucose monitoring (baseline HbA1c≥ 7.0%, HbA1c reduction greater than or equal to 0.5%), Hypoglycaemia Responders (baseline HbA1c < 7.0%) who demonstrated decreased time < 3.9 mmol/l while remaining within target HbA1c, and HbA1c Non-Responders (baseline HbA1c≥ 7.0%, HbA1c reduction less than 0.5%). Subjects participated in semi-structured interviews focusing on their psychosocial experiences with continuous glucose monitoring.

Results  Three major themes were identified that differentiated Responders (including both the HbA1c and Hypoglycaemia groups) from Non-Responders: (i) coping with frustrations-Responders used self-controlled rather than emotions-based coping when faced with continuous glucose monitoring frustrations; (ii) use of information-Responders used retrospective pattern analysis, not just minute-by-minute data analysis, in glycaemic management; (iii) ‘significant other’/spousal involvement-Responders endorsed interest, encouragement and participation by their loved ones. Both Responders and Non-Responders expressed body image concerns when wearing continuous glucose monitoring devices.

Conclusions  This qualitative study points to the importance of coping skills, retrospective review of data, and ‘significant other’ involvement in the effective use of continuous glucose monitoring. These findings will inform clinical initiatives to improve patient selection and training in the use of this new technology and have served as the basis for development of quantitative surveys to be used in clinical practice.

View Fulltext